Vaios, E. J., Shenker, R. F., Hendrickson, P., D’Anna, R., Niedzwiecki, D., Carpenter, D. J., … Reitman, Z. (2022). Impact of Single and Dual Immune Checkpoint Blockade on Risk of Radiation Necrosis among Patients with Brain Metastases Treated with Stereotactic Radiosurgery. In INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (Vol. 114, pp. E82–E83).

Vaios, E. J., R. F. Shenker, P. Hendrickson, R. D’Anna, D. Niedzwiecki, D. J. Carpenter, W. Floyd, et al. “Impact of Single and Dual Immune Checkpoint Blockade on Risk of Radiation Necrosis among Patients with Brain Metastases Treated with Stereotactic Radiosurgery.” In INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 114:E82–83, 2022.

Vaios EJ, Shenker RF, Hendrickson P, D’Anna R, Niedzwiecki D, Carpenter DJ, et al. Impact of Single and Dual Immune Checkpoint Blockade on Risk of Radiation Necrosis among Patients with Brain Metastases Treated with Stereotactic Radiosurgery. In: INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS. 2022. p. E82–3.

Vaios, E. J., et al. “Impact of Single and Dual Immune Checkpoint Blockade on Risk of Radiation Necrosis among Patients with Brain Metastases Treated with Stereotactic Radiosurgery.” INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, vol. 114, no. 3, 2022, pp. E82–83.

Vaios EJ, Shenker RF, Hendrickson P, D’Anna R, Niedzwiecki D, Carpenter DJ, Floyd W, Winter SF, Dietrich J, Floyd SR, Kirkpatrick JP, Mullikin TC, Allen KJ, Salama AKS, Clarke J, Reitman Z. Impact of Single and Dual Immune Checkpoint Blockade on Risk of Radiation Necrosis among Patients with Brain Metastases Treated with Stereotactic Radiosurgery. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS. 2022. p. E82–E83.